Epstein Secrets

tment fund 1MDB. In what the journal casts as a move to assuage shareholders Goldman said four executives: chief Executive David Solomon, President John Waldron, Chief Financial Officer Stephen Scherr and the head of Goldman's international business, Richard Gnodde will give up $31 million in pay this year.

patients even as other drugs for the disease begin to reach the market." USA Today (10/22, Rice, 10.31M) reports that Gilead Chief Medical Officer Merdad Parsey EFTA00135821 said the drug has approvals or authorizations in around 50 countries. The New Ynrk TIMP4 (10/22, Levenson, 18.61M) reports the FDA's

tment fund 1MDB. In what the journal casts as a move to assuage shareholders Goldman said four executives: chief Executive David Solomon, President John Waldron, Chief Financial Officer Stephen Scherr and the head of Goldman's international business, Richard Gnodde will give up $31 million in pay this year.

ws/health/2020/10/22/fda-approves-remdesivir-covid-19- hospital-patients/3733648001/> (10/22, Rice, 10.31M) reports that Gilead Chief Medical Officer Merdad Parsey said the drug has approvals or authorizations in around 50 countries. The New York Times <https://www.nytimes.com/2020/10/22/us/remdesivir-fda-appr

stment fund 1MDB. In what the journal casts as a move to assuage shareholders Goldman said four executives: chief Executive David Solomon, President John Waldron, Chief Financial Officer Stephen Scherr and the head of Goldman's international business, Richard Gnodde will give up $31 million in pay this year.

patients even as other drugs for the disease begin to reach the market." USA Today (10/22, Rice, 10.31M) reports that Gilead Chief Medical Officer Merdad Parsey said the drug has approvals or authorizations in around 50 countries. EFTA00148471 The New York Times (10/22, Levenson, 18.61M) reports the FDA's